Two studies utilizing Myocardial Solutions’ MyoStrain® in were presented at the Global Cardio-Oncology Summit 2018 in Tampa, Florida on September 27-28. The two abstracts report on the interim results of the Adult Oncology Cardiotoxicity study (NCT03543228) at Marien Hospital in Hamburg, Germany...
A manuscript on a multi-center clinical study examining the inter-operator repeatability of global and regional MyoStrain was published on September 20, 2018 in Scientific Reports. The study evaluated the inter-study reproducibility, as well as intra- and inter-observer reproducibility...
Five abstracts utilizing Myocardial Solutions’ MyoStrain® were presented at CMR 2018: The Joint EuroCMR / SCMR Meeting in Barcelona, Spain. The conference took place in Barcelona, Spain from January 31 – February 3, 2018.The papers span a variety of subjects including MyoStrain’s reliability...
